Christoph
Christoph Schlegel is a partner in Bain & Company's Frankfurt office. He is an expert in Bain's Healthcare, Telecommunications and Technology practices.
He has nearly 15 years of global consulting experience, having advised clients across Bain's Frankfurt, Zurich, Munich, Dubai, Chicago and Stockholm offices.
Christoph advises clients in a variety of industries, with a focus in pharmaceuticals, biotech, medtech and telecommunications. He holds deep expertise in strategy development, in particular strategy in uncertainty, digitalization, consumer strategy and marketing as well as organization.
Christoph studied in St. Gallen and London and holds an MA in Finance and Capital Market Theory.
Bain Partners Christoph Schlegel and Hans Joachim Heider discuss the future of autonomous driving.
Recent Insights
- “Healthcare Private Equity in Europe: Funds Take On More Risk in a Hot Market,” レポート, 2022年3月15日
- “Biopharma: Traditional Pharma Services Lead the Way ,” レポート, 2022年3月15日
- “Life Sciences Tools: Diagnostics Deals on the Rise ,” レポート, 2022年3月15日
- “Healthcare Private Equity in Europe: Steady Dealmaking despite Many Deferrals,” レポート, 2021年3月16日
- “Biopharma: Commercialization Support Services Are Thriving ,” レポート, 2021年3月16日